Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT-6548 in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
NCT03461146Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Mar 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of vadadustat in anemia, sponsored by Mitsubishi Tanabe Pharma. Primary endpoints: Mean Hemoglobin Level at 24 weeks, Hemoglobin Level at Each Assessment Time Point at 24 weeks and 3 more. Started Mar 2018; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03461146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03461146.